Friday, March 23, 2012

Japan Pharma News - Daiichi Sankyo files denosumab for approval in Japan

  1. Daiichi Sankyo Files for Approval in Japan to Market AMG 162 (denosumab), a Treatment for Osteoporosis
  2. Daiichi Sankyo to Develop Narcotic Analgesic Hydromorphone Hydrochloride in Japan
  3. 30 Indian companies to participate in CPHI Japan 2012 , as part of "Brand India Initiative"  of the Indian Ministry of Commerce
  4. BIKEN sign agreement with MSD for domestic marketing for 3 Flu vaccines - Influenza HA Vaccine, HA Flubik, HA Syringe, with a view to expand market reach. Mitsubishi Tanabe already sells these vaccines in Japan

No comments:

Post a Comment